Adriana Arcia, Niurka Suero-Tejeda, Nicole Spiegel-Gotsch, Jose A Luchsinger, Mary Mittelman, Suzanne Bakken
Helping Hispanic Family Caregivers of Persons With Dementia "Get the Picture" About Health Status Through Tailored Infographics
The Gerontologist
management lymphoid malignancies requires substantial health system resources total national health expenditure might influence populationbased lymphoid malignancy survival studied longterm survival patients 12 lymphoid malignancy types examined whether different levels national health expenditure might explain differences lymphoid malignancy prognosis european countries regions observational retrospective populationbased study analysed eurocare6 dataset patients aged 15 older diagnosed 2001 2013 one 12 lymphoid malignancies defined according international classification disease oncology third edition classification followed 2014 jan 1 2001dec 31 2014 countries classified according mean total national health expenditure quartile 200113 lymphoid malignancy 5year 10year agestandardised relative survival asrs calculated using period approach generalised linear models indicated effects age diagnosis gender total national health expenditure relative excess risk death rer 82 cancer registries 61 regional 21 national 27 european countries provided data eligible 10year survival estimates comprising 890 730 lymphoid malignancy cases diagnosed 200113 median followup time 13 years iqr 1314 12 lymphoid malignancies 10year asrs europe highest hairy cell leukaemia 826 95 ci 789865 hodgkin lymphoma 793 786799 lowest plasma cell neoplasms 295 289300 rer increased age diagnosis particularly 5564 years 75 years older lymphoid malignancies women higher asrs men lymphoid malignancies except precursor b natural killer cell nototherwise specified lymphoblastic lymphoma leukaemia 10year asrs lymphoid malignancy higher rer lower countries highest national health expenditure quartile countries lowest quartile decreasing pattern quartiles many lymphoid malignancies 10year asrs nonhodgkin lymphoma representative class lymphoid malignancies based number incident cases 593 95 ci 587600 first quartile 576 552587 second quartile 554 543565 third quartile 447 436458 fourth quartile reference european mean rer 080 95 ci 079082 first 091 090093 second 094 092096 third 145 142148 fourth quartiles total national health expenditure associated geographical inequalities lymphoid malignancy prognosis policy decisions allocating economic resources implementing evidencebased models care needed reduce differences italian ministry health european commission estonian research council